Clinical Trial Update: Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating optimal antiplatelet therapy for patients with acute coronary syndrome at high risk of both bleeding and ischemia; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage | Phase 4 | Status: COMPLETED